ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
128.019,07
-0,21%
S&P 500
5.298,64
0,03%
US Dollar vs BRL
5,1119
-0,35%
Bitcoin
67.102,56
2,83%
Brent Oil
83,405
0,24%
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. X4 Pharmaceuticals Inc (XFOR)

  7. X4 Pharmaceuticals Inc (XFOR) Notícias

XFOR

X4 Pharmaceuticals (XFOR)

X4 Pharmaceuticals Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:XFOR
DataHoraFonteTítuloCódigoCompanhia
09/05/202407:58Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XFORX4 Pharmaceuticals Inc
11/03/202418:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XFORX4 Pharmaceuticals Inc
11/03/202417:16Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:XFORX4 Pharmaceuticals Inc
28/02/202419:52Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:XFORX4 Pharmaceuticals Inc
14/02/202418:44Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:XFORX4 Pharmaceuticals Inc
14/02/202418:32Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:XFORX4 Pharmaceuticals Inc
25/01/202418:23Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:XFORX4 Pharmaceuticals Inc
09/11/202319:11Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:XFORX4 Pharmaceuticals Inc
18/10/202317:00Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:XFORX4 Pharmaceuticals Inc
25/08/202301:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:XFORX4 Pharmaceuticals Inc
26/06/202317:16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:XFORX4 Pharmaceuticals Inc
23/06/202316:27Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:XFORX4 Pharmaceuticals Inc
21/06/202307:06Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:XFORX4 Pharmaceuticals Inc
21/06/202307:03Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:XFORX4 Pharmaceuticals Inc
16/06/202317:05Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:XFORX4 Pharmaceuticals Inc
09/06/202317:13Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:XFORX4 Pharmaceuticals Inc
01/06/202317:40Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:XFORX4 Pharmaceuticals Inc
01/06/202317:17Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:XFORX4 Pharmaceuticals Inc
26/05/202316:05Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:XFORX4 Pharmaceuticals Inc
04/05/202317:24Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:XFORX4 Pharmaceuticals Inc
27/04/202317:27Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:XFORX4 Pharmaceuticals Inc
25/04/202317:11Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:XFORX4 Pharmaceuticals Inc
21/03/202317:25Edgar (US Regulatory)Annual Report (10-k)NASDAQ:XFORX4 Pharmaceuticals Inc
14/02/202319:41Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:XFORX4 Pharmaceuticals Inc
12/12/202216:35TipRanksX4 Pharmaceuticals (XFOR) Receives a New Rating from Brookline Capital MarketsNASDAQ:XFORX4 Pharmaceuticals Inc
09/12/202208:04Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:XFORX4 Pharmaceuticals Inc
07/12/202209:12TipRanksX4 Pharma Tanks on Public OfferingNASDAQ:XFORX4 Pharmaceuticals Inc
30/11/202209:35TipRanksB.Riley Financial Keeps Their Buy Rating on X4 Pharmaceuticals (XFOR)NASDAQ:XFORX4 Pharmaceuticals Inc
29/11/202221:05TipRanksBrookline Capital Markets Sticks to Its Buy Rating for X4 Pharmaceuticals (XFOR)NASDAQ:XFORX4 Pharmaceuticals Inc
07/11/202223:07TipRanksX4 Pharmaceuticals (XFOR) Receives a Buy from Stifel NicolausNASDAQ:XFORX4 Pharmaceuticals Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:XFOR

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
HBOR3
HELBOR ON
BOV
GFSA3
GAFISA ON
BOV
TPIS3
TRIUNFO PART ON
BOV
PRIO3
PETRORIO ON
BOV
ENAT3
ENAUTA ON
BOV
RPMG3
PET MANGUINH ON
BOV
IRBR3
IRB BRASIL ON
BOV
LIGT3
LIGHT ON
BOV
GOLL4
GOL PN
BOV
HAGA3
HAGA ON
BOV
RRRP3
3R Petroleum Oleo E Gas ... ON
BOV
HOOT4
HOTEIS OTHON PN
BOV
BRSR6
BANRISUL PNB
BOV
BHIA3
Grupo Casas Bahia ON
BOV
RCSL3
RECRUSUL ON
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados